Surpass Evolve
Payments companies reported to CMS as associated with Surpass Evolve. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Surpass Evolve, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Surpass Evolve
These are the largest totals companies reported as associated with Surpass Evolve. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Alexander Coon | Baltimore, MD | Neurological Surgery | $490,030.19 |
| Justin Singer | Grand Rapids, MI | Neurological Surgery | $201,932.45 |
| Ajay Wakhloo | Worcester, MA | Diagnostic Radiology | $200,805.43 |
| Geoffrey Colby | Los Angeles, CA | Neurological Surgery | $168,972.41 |
| Santiago Ortega Gutierrez | Iowa City, IA | Vascular & Interventional Radiology | $98,242.43 |
| Ben Waldau | Sacramento, CA | Neurological Surgery | $81,522.04 |
| Jan-Karl Burkhardt | New York, NY | Neurological Surgery | $75,300.28 |
| Peter Kan | Galveston, TX | Neurological Surgery | $71,971.70 |
| Adam Arthur | Memphis, TN | Neurological Surgery | $62,784.90 |
| Brian Jankowitz | Philadelphia, PA | Neurological Surgery | $59,731.08 |
Prescribed Surpass Evolve?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.